Which Stock Worth Buying? CorMedix Inc (CRMD) or Visa Inc. (V)

The shares of CorMedix Inc (NYSE:CRMD) and Visa Inc. (NYSE:V) were among the active stocks of the last trading sessions. CorMedix Inc (NYSE:CRMD) soared to 19.23% closing at the price of $1.55 whereas the shares of Visa Inc. (NYSE:V) declined -2.39% with the decrease of -3.47 points closing at the price of $141.89. CorMedix Inc has currently increase 579.53% in its stock over the period of 6-months while its rival Visa Inc. added 17.54% in the previous 6-months.

Now we have to analyze the facts that if the stocks were worthy off investors’ money? The facts to analyze here are risks, profitability, returns and price trends.

Returns and Profitability

Profitability and returns are the main reason of investment, the investors are looking for profits that they get and return they should expect over the period of time.

The first and foremost return that is considered while making an investment is the ROI or Return on Investment. The ROI is the ratio between the profit against the cost of investment. Currently the ROI of CorMedix Inc (NYSE:CRMD) is 0% while the ROI of Visa Inc. (NYSE:V) is 15.7%. Another figure that is to be considered while analyzing the profitability of a share is its EBITDA margin, CRMD’s EBITDA Margin is -2.86 whereas V’s is 24.4.

Both the profitability ratios suggest that Visa Inc. (NYSE:V) is more suitable investment in terms of profitability and return.

EPS & Surprise Factor

CorMedix Inc (NYSE:CRMD) reported $-0.1/share EPS for the previous quarter where analysts were predicting an EPS to be $-0.1/share Thus meeting the analyst Estimates with a Surprise Factor of 0 Percent. While, Visa Inc. (NYSE:V) reported EPS of $1.2/share in the last quarter. The analysts projected EPS of $1.09/share depicting a Surprise of 10.1 Percent.

Taking a look at Earnings per Share, Visa Inc. tends to be beating the analyst estimates more than CorMedix Inc. so V is more profitable than CRMD.

Technical Analysis of CorMedix Inc & Visa Inc.

Moving average convergence divergence (MACD) shows that CorMedix Inc (NYSE:CRMD) is on a PRICE RELATIVITY trend While Visa Inc. (NYSE:V) is on PRICE RELATIVITY trend. The trend for the past 10-days shows that the CorMedix Inc was in BULLISH territory and Visa Inc. was in BEARISH territory.

CRMD’s current statistics gauge that the stock candle is BULLISH with HIGH volatility. While V’s candle is BEARISH with HIGH.

EPS Growth Rate: CRMD’s 0% versus V’s 19.11%

Another shareholder value can be analyzed through the EPS growth rate; the next 5 years EPS growth rate is predicted by the analysts after the analyzing the previous trends. The next 5 year EPS growth rate of CorMedix Inc (NYSE:CRMD) is predicted at 0% while Visa Inc. (NYSE:V) stands at 19.11%. These numbers suggest that V is more suitable investment in terms of EPS growth rate.

Financial Risk and Liquidity Concerns

The current ratio and the debt ratio are the two ratios that show the investor how quickly the company is able to payout its debt and how quickly it can cover its obligations. The current ratio of CRMD stands at 0.5 while V is at 1.7 whereas the debt ratio of the prior is 0 while the debt ratio of the later is 0.6.

The values of the both ratios suggest that V is more suitable investment when the liquidity and risk is the main concern.

Analyst Recommendations

While making an investment, another main factor to consider before investing is the analyst recommendation on the scale of 1 to 5 where 1 is strong buy, 2 is buy, 3 is hold, 4 is Sell and 5 is strong sell. Analyst recommend 2 for CRMD and 1.7 for V which means CRMD has Buy rating whereas V has Buy rating.

Another recommendation of analyst that is to be considered worthy is the price target. The mare price or price trend does not suggest the suitability of a stock. The price target set by analyst is also to be considered while investing as it suggests to what extent the stock will rise or fall in the near future. The price target set for CRMD is $3 which is 48.33% of its current price while V has price target of 162.35 which is 12.6% of its current price.

Valuation Ratios

Valuation is the process of determining the company’s worth for an investor, the valuation ratios give an insight to that worthiness.

CRMD currently has price to earning P/E ratio of 0 whereas V has 39.13 while the forward P/E ratio for the prior stands at 0 and for the later it depicts the value of 26.67.

The price to Book P/B for CRMD is 0, Price to Sale is at 688.59 and for V these ratios stand at 11.39 and 15.91.